Dynamics of gamma interferon, interleukin-12 (IL-12), IL-10, and transforming growth factor β mRNA expression in primary Mycobacterium bovis BCG infection in guinea pigs measured by a real-time fluorogenic reverse transcription PCR assay

被引:24
作者
Kawahara, M
Nakasone, T
Honda, M
机构
[1] Natl Inst Infect Dis, Shinjuku Ku, Tokyo 1628640, Japan
[2] Japanese Fdn AIDS Prevent, Minato Ku, Tokyo, Japan
[3] Japan Sci & Technol Corp, Kawaguchi, Saitama 3320012, Japan
关键词
D O I
10.1128/IAI.70.12.6614-6620.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
The guinea pig has been utilized as a model for studying infectious diseases because its reactions closely resemble those of humans biologically and immunologically. However, the cytokine responses in this animal remain to be studied. Initially, we established a quantitative assay using a real-time reverse transcription-PCR (RT-PCR) to measure guinea pig gamma interferon (IFN-gamma), interleukin-12 (IL-12), IL-10, and transforming growth factor beta (TGF-beta) mRNA. By preparing primer-fluorogenic probe sets for these cytokines and standard RNA templates corresponding to the target sequence of each cytokine, we obtained linear standard curves essential for quantitative determination. In guinea pigs immunized by intradermal (i.d.) vaccination with the Tokyo strain of Mycobacterium bovis BCG (0.1 mg) or else hyperimmunized with the same vaccine (10 mg) given intravenously (i.v.), peripheral blood mononuclear cells (PBMCs) at 4 weeks showed an increase in IFN-gamma mRNA expression in the latter but not the former animals. However, at week 10, IFN-gamma mRNA expression was markedly elevated in PBMCs, spleen cells, and cells in bronchoalveolar lavage fluid in both the i.d.- and the i.v.-immunized animals, the level of expression being 10 times higher in the latter. In contrast, the expression levels of IL-12 mRNA in PBMCs, spleen cells, and BAL cells were not enhanced in either group at 10 weeks postimmunization. The expression of IL-10 and TGF-beta increased slightly only in PBMCs. Regardless of differences in the levels of cytokine responses, the magnitudes of the purified protein derivative of tuberculin-specific delayed-type hypersensitivity (DTH) skin reactions for the two groups did not differ significantly at 8 weeks postvaccination. In this study, we quantitatively measured IL-10, IL-12, TGF-beta, and IFN-gamma mRNA in BCG-immunized guinea pigs and showed that the level of IFN-gamma mRNA expression does not necessarily reflect the magnitude of the DTH response, suggesting that there may be an intricate relationship between protective immunity, the level of IFN-gamma, and the DTH response. Thus, our quantitative assay would be of use for the development of vaccines using guinea pig models.
引用
收藏
页码:6614 / 6620
页数:7
相关论文
共 45 条
[1]
MYCOBACTERIAL INFECTION IN GUINEA-PIGS [J].
BALASUBRAMANIAN, V ;
WIEGESHAUS, EH ;
SMITH, DW .
IMMUNOBIOLOGY, 1994, 191 (4-5) :395-401
[2]
CYTOKINE PRODUCTION AT THE SITE OF DISEASE IN HUMAN TUBERCULOSIS [J].
BARNES, PF ;
LU, SZ ;
ABRAMS, JS ;
WANG, E ;
YAMAMURA, M ;
MODLIN, RL .
INFECTION AND IMMUNITY, 1993, 61 (08) :3482-3489
[3]
BERMUDEZ LE, 1993, J IMMUNOL, V150, P1838
[4]
A STRATEGY TO IMPROVE THE EFFICACY OF VACCINATION AGAINST TUBERCULOSIS AND LEPROSY [J].
BRETSCHER, PA .
IMMUNOLOGY TODAY, 1992, 13 (09) :342-345
[5]
ESTABLISHMENT OF STABLE, CELL-MEDIATED-IMMUNITY THAT MAKES SUSCEPTIBLE MICE RESISTANT TO LEISHMANIA-MAJOR [J].
BRETSCHER, PA ;
WEI, GJ ;
MENON, JN ;
BIELEFELDTOHMANN, H .
SCIENCE, 1992, 257 (5069) :539-542
[6]
Campbell EM, 1997, J IMMUNOL, V159, P1482
[7]
Antigenic stimulation by BCG vaccine as an in vivo driving force for SIV replication and dissemination [J].
Cheynier, R ;
Gratton, S ;
Halloran, M ;
Stahmer, I ;
Letvin, NL ;
Wain-Hobson, S .
NATURE MEDICINE, 1998, 4 (04) :421-427
[8]
EFFECTS OF DIET AND GENETICS ON MYCOBACTERIUM-BOVIS BCG VACCINE EFFICACY IN INBRED GUINEA-PIGS [J].
COHEN, MK ;
BARTOW, RA ;
MINTZER, CL ;
MCMURRAY, DN .
INFECTION AND IMMUNITY, 1987, 55 (02) :314-319
[9]
COHN ML, 1962, AM REV RESPIR DIS, V86, P95
[10]
IDENTIFICATION OF AN EFFECTIVE VACCINE AGAINST TUBERCULOSIS [J].
COMSTOCK, GW .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (02) :479-480